Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
PARACETAMOL PHENYLEPHRINE HYDROCHLORIDE
Procter & Gamble (Health & Beauty Care) Ltd
1000/12.2 Milligram
Powder for Oral Solution
2011-12-16
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 1000mg, phenylephrine hydrochloride 12.2mg, Powder for oral solution, Blackcurrant flavour 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One sachet contains: 1000mg Paracetamol 12.2mg Phenylephrine hydrochloride (equivalent to 10mg phenylephrine base) Excipients Sucrose 2351mg Aspartame 53mg Carmoisine 4.9mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for oral solution, sachet Purple powder 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For relief of symptoms of colds and influenza, including the relief of headaches, aches and pains, sore throat, nasal congestion and lowering of temperature. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dissolve the contents of one sachet in a standard mug of hot, but not boiling, water (approx. 250ml). Allow to cool to a drinkable temperature. Adults: One sachet May be repeated every 4-6 hours as required Adolescents over 15 years of age: One sachet May be repeated every 6 hours as required Maximum of 4 doses (4 sachets) in 24 hours Not recommended for children under 15 years, except on medical advice. Elderly: No special dosage modifications are required. 4.3 CONTRAINDICATIONS Hypersensitivity to paracetamol, phenylephrine or any of the excipients Severe ischaemic heart disease Severe hepatic impairment Moderate to severe renal impairment Hypertension Severe hyperthyroidism Narrow-angle glaucoma Use in patients who are currently taking or have taken monoamine oxidase inhibitors (MAOIs) within the last two weeks IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 03/02/2012_ _CRN 2111397_ _page number: 1_ Use in patients with urinary retention Use in patients who are current Đọc toàn bộ tài liệu